Anti-CD20 in SLE (AC002)

Robert Eisenberg
The purpose of this study is to determine the safety and effectiveness of rituximab (anti-CD20) in treating systemic lupus erythematosus (SLE). White blood cells in the body called B cells give off substances that are active in promoting SLE disease. Researchers have found that anti-CD20 can block production of these substances in another disease. This study explores whether anti-CD20 will also be safe in people with SLE and whether it may be effective in treating...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.